ODAD2: A Potential Drug Target and Biomarker (G55130)

Target Name: ODAD2

NCBI ID: G55130

ODAD2

ODAD2: A Potential Drug Target and Biomarker

ODAD2 (Armadillo repeat-containing protein 4) is a protein that is expressed in a variety of tissues throughout the body, including the brain, pancreas, and heart. It is characterized by the presence of an armadillo repeat, which is a specific type of protein that is found in many proteins that are involved in cell signaling.

One of the things that makes ODAD2 stand out is its potential as a drug target. Its armadillo repeat has been shown to be involved in a number of different processes in the body, including the regulation of cell signaling pathways and the development of certain diseases. As a result, ODAD2 has been identified as a potential drug target for a number of different diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In addition to its potential as a drug target, ODAD2 has also been shown to be a potential biomarker for a number of different diseases. Its armadillo repeat has been shown to be expressed in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, ODAD2 has been identified as a potential biomarker for these diseases, and may be useful for the development of diagnostic tests and therapies.

ODAD2 is also of interest to researchers because of its structure and biology. Its armadillo repeat is a type of protein that is known for its ability to interact with other proteins and molecules, and its structure has been shown to be involved in a number of different cellular processes. As a result, ODAD2 has been a focus of research in the laboratory, and its properties have been studied in a variety of different conditions, including cancer, neurodegenerative diseases, and autoimmune disorders.

In addition to its potential as a drug target and biomarker, ODAD2 is also of interest to researchers because of its potential role in the development of certain diseases. For example, studies have shown that ODAD2 is often expressed in the brains of individuals with Alzheimer's disease, and its expression has been linked to the development of this disease. Additionally, ODAD2 has also been shown to be involved in the development of other neurological disorders, including Parkinson's disease and multiple sclerosis.

Overall, ODAD2 is a protein that has the potential to be a drug target and biomarker for a number of different diseases. Its armadillo repeat and structure have make it an attractive target for researchers, and its expression has been linked to the development of a variety of different neurological disorders. Further research is needed to fully understand its role and potential as a drug and biomarker.

Protein Name: Outer Dynein Arm Docking Complex Subunit 2

Functions: Component of the outer dynein arm-docking complex (ODA-DC) that mediates outer dynein arms (ODA) binding onto the doublet microtubule (PubMed:27486780). Involved in mediating assembly of both ODAs and their axonemal docking complex onto ciliary microtubules (PubMed:23849778)

The "ODAD2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ODAD2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets